Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Asset Utilization Ratio (2016 - 2026)

Gyre Therapeutics has reported Asset Utilization Ratio over the past 14 years, most recently at 0.72 for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 15.11% to 0.72 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.72 through Dec 2025, down 15.11% year-over-year, with the annual reading at 0.8 for FY2025, 8.51% down from the prior year.
  • Asset Utilization Ratio was 0.72 for Q4 2025 at Gyre Therapeutics, up from 0.69 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 16.8 in Q3 2023 and troughed at 0.05 in Q2 2021.
  • The 5-year median for Asset Utilization Ratio is 0.76 (2025), against an average of 1.99.
  • Year-over-year, Asset Utilization Ratio skyrocketed 29610.75% in 2023 and then plummeted 94.92% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.11 in 2021, then surged by 1515.85% to 1.77 in 2022, then rose by 1.5% to 1.79 in 2023, then plummeted by 52.95% to 0.84 in 2024, then decreased by 15.11% to 0.72 in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Asset Utilization Ratio are 0.72 (Q4 2025), 0.69 (Q3 2025), and 0.72 (Q2 2025).